A Speedy Intervention for Heart Attacks, Dr. Harry Selker & Dr. Atul Deshpande, Immediate Therapeutics
This is the 2026 BioTech Nation "5":
Five Companies Ready to Make a Difference.
We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco.
Five Companies Ready to Make a Difference.
We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco.
On this episode of BioTech Nation...
Dr. Harry Selker & Dr. Atul Deshpande of Immediate Therapeutics speak with Moira about a new treatment that could be administered to heart attack patients right away...potentially before they even arrive at the hospital. Already successfully tested in Phase 2, it’s ready
to go into final pivotal trials in Ambulances and Emergency Rooms.
For more information about BioTech Nation and the companies featured here, visit: TechNation.com
